X-100669296-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_014467.3(SRPX2):c.1144G>A(p.Val382Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000581 in 1,205,492 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000037 ( 0 hom., 1 hem., cov: 20)
Exomes 𝑓: 0.0000027 ( 0 hom. 1 hem. )
Consequence
SRPX2
NM_014467.3 missense
NM_014467.3 missense
Scores
2
6
9
Clinical Significance
Conservation
PhyloP100: 3.84
Genes affected
SRPX2 (HGNC:30668): (sushi repeat containing protein X-linked 2) This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and cognitive disability. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRPX2 | ENST00000373004.5 | c.1144G>A | p.Val382Met | missense_variant | 10/11 | 1 | NM_014467.3 | ENSP00000362095.3 | ||
SRPX2 | ENST00000640282.1 | c.142-1511G>A | intron_variant | 5 | ENSP00000491188.1 | |||||
SRPX2 | ENST00000638920.1 | n.1147G>A | non_coding_transcript_exon_variant | 9/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000371 AC: 4AN: 107803Hom.: 0 Cov.: 20 AF XY: 0.0000331 AC XY: 1AN XY: 30199
GnomAD3 genomes
AF:
AC:
4
AN:
107803
Hom.:
Cov.:
20
AF XY:
AC XY:
1
AN XY:
30199
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183343Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67783
GnomAD3 exomes
AF:
AC:
2
AN:
183343
Hom.:
AF XY:
AC XY:
1
AN XY:
67783
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1097689Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363055
GnomAD4 exome
AF:
AC:
3
AN:
1097689
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
363055
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000371 AC: 4AN: 107803Hom.: 0 Cov.: 20 AF XY: 0.0000331 AC XY: 1AN XY: 30199
GnomAD4 genome
AF:
AC:
4
AN:
107803
Hom.:
Cov.:
20
AF XY:
AC XY:
1
AN XY:
30199
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.1144G>A (p.V382M) alteration is located in exon 10 (coding exon 9) of the SRPX2 gene. This alteration results from a G to A substitution at nucleotide position 1144, causing the valine (V) at amino acid position 382 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 30, 2021 | This sequence change replaces valine with methionine at codon 382 of the SRPX2 protein (p.Val382Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs148241932, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with SRPX2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at